Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 5 mg / 850 mg Tablets Under Fed Conditions.

NCT07633015 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study in Healthy Subjects

Interventions

DRUG: Test. Empagliflozin/metformin 5/850 mg
DRUG: Synjardy 5/850 mg tablet, Reference

Sponsor

ADIUM